Mission BioCapital Platinum Program Application Form

Platinum Program Applications Are Now Closed
Thank you for your interest in our Platinum Program. We are no longer accepting applications at this time. Please check back in Spring 2026 when applications reopen.

DRAFT PPA Form 2025

Company

Have you formerly incorporated the company?
Business Address:
Business Address:
City
State/Province
Zip/Postal
Country
0 of 250 max characters

Sector

Technology Sector: (select all that apply)
Therapeutic Modality: (select all that apply)
Therapeutic Area: (select all that apply)
Primary Technology Sector: (select one)
Primary Therapeutic Modality: (select one)
Primary Therapeutic Area: (select one)

Location

Please indicate which incubator location(s) you’re interested in (select at least one):
For the next field:
  • Applicants should select U.S. if they selected LA, San Diego, San Francisco/surroundings, New Haven, Boston/Cambridge/surroundings, Princeton, NYC, RTP, Philadelphia, or Dallas in the previous question.
  • Applicants should select EU if they are currently working in an EU member space or if they selected Heidelberg or Paris in the previous question.
  • Applicants should select both if both of these apply.
Select one or both of the following:
Is your company an academic spin-out?

Team

%

Please Note: Your response to the next question will not qualify/disqualify you for consideration in our process to award Platinum Tickets. Applications and pitches will be reviewed based on merit and other requirements for the program and not based on your answers to the following question. This information will be used only to help us ensure that we are running an equitable process.

Mission BioCapital strongly encourages under-represented founders to apply. If you identify as under-represented in the biotech industry please self-identify here*: (check all applicable boxes)

*While we know that checking boxes can never fully capture the complexity of your identity, the above options are included because they have been identified in peer-reviewed literature and reports as identities and demographics that are measurably under-represented in the biotech industry. This list is not meant to be exhaustive. There are many other identities and demographics that are not widely discussed as under-represented but that we believe are important to support.

plus1 Add minus1 Remove

Funding

Currency Type

Non-Confidential Presentation

Please upload a non-confidential presentation (10 slide maximum) that addresses the following points:

  • Clinical unmet need and addressable patient population
  • Competitive advantage over current state of the art
  • Proprietary aspect(s) & current state of any IP
  • Regulatory and reimbursement plans
  • Strongest data-to-date
  • Use of proceeds from the Platinum ticket
  • Team (management, Board of Directors, Scientific Advisory Board)

Maximum file size: 33.55MB

Select file from your computer. PDF format only. Size: up to 10 pages/slides.

Other